Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
How Long Do the Effects Last
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials
Regulatory Status GLP-3 (Reta) (LY3437943) is an investigational compound developed by Eli Lilly
Failing to account for this when switching vial sizes is one of the most common and dangerous reconstitution errors
All preclinical data is consistently positive across musculoskeletal, GI, and neurological outcomes
US$ 21.61
US$ 21.39
US$ 27.95
US$ 21.94
US$ 27.83
US$ 21.14
US$ 25.60
US$ 25.25
